0%
Products > TruDiagnosis® > TruArray HE Assay
TruArray HE is a qualitative test for the rapid detection of herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), and varicella zoster virus (VZV) in cerebrospinal fluid (CSF) from individuals with signs and symptoms of viral meningitis and/or encephalitis. As an adjunct to other laboratory test results and information, TruArray HE can aid in the laboratory diagnosis of a viral infection in individuals with a suspicion of meningitis, encephalitis or meningoencephalitis.
Simultaneous detection of HSV1, HSV2, and and VZV at 10 genome copies each in a single set.
* All of Akonni Biosystems tests are currently for Research Use Only, and are not for use in diagnostic procedures. Akonni is interacting with the Food & Drug Administration (FDA) in order to develop and prepare pre-market notifications seeking clearance to market these products as diagnostic assays in the U.S.
Based on its recent analysis of the microarrays in molecular diagnostics (MDx) market, Frost & Sullivan recognizes Akonni Biosystems with the 2017 North American New Product Innovation Award.
Akonni’s integrated MDx system, TruDiagnosis®, is revolutionizing the point-of-care molecular testing market by enabling target detection from a variety of sample types. TruDiagnosis® is powered by TruArray®, a patented 3D gel-drop microarray technology for sample screening that instantly indicates the presence of disease markers in real time.
Download:
